Online
|
|
for steady returns
Posted by :
karshinGSK may give you over 25% return in one year at CMP...
GSK PHARMA Q2 Numbers Out
Posted by : pms.swastika
GSK PHARMA Q2 Numbers Out:
Net Profit at Rs. 141.10 Cr Vs Rs. 132.00 Cr (+7.00%) (YoY)
Net Sales at Rs. 511.80 Cr Vs Rs. 456.90 Cr (+12.02%) (YoY)
Regards
Swastika PMS...
NSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 51181 lacs for quarter ending on 30-SEP-2009 against Rs. 45695 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 14108 lacs for the quarter ending on 30-SEP-2009 against Rs. 13197 lacs for the quarter ending on 30-SEP-2008....
BSE Announcements on GlaxoSmithKline
Posted by : MMB Messenger
GlaxoSmithKline Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended September 30, 2009:
The Company has posted a net profit of Rs 1410.80 million for the quarter ended September 30, 2009 as compared to Rs 1319.70 million for the quarter ended September 30, 2008. Total Income has increased from Rs 4709.00 million for the quarter ended September 30, 2008 to Rs 5182.80 million for the quarter ended September 30, 2009. ...
GSK Pharma
Posted by : GuestYes, the H1N1 vaccine can make GSK India 10 times more cash rich than the present cash rich situation in which they are now....
BSE Announcements on GlaxoSmithKline
Posted by : MMB MessengerGlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 30, 2009, inter alia, to consider, approval of unaudited financial results for the 3rd quarter June-September 2009 (Q3)....
gsk pharma
Posted by : GuestWill the management make the shareholders Diwali merrier by declaring bonus? Will Pandemrix vaccine can make this 10 times more cash rich as they are now....
Block Deal in GSK Pharma
Posted by : GuestThere is a possibility as GSK is taking steps forward to march ahead. Will Pandemrix vaccine can make GSK India`s bank accounts swell? Can GSK India make their Diwali special this time? Only time can tell....
Block Deal in GSK Pharma
Posted by :
INOUWas there a block deal in GSK Pharma today?...
gsk joining hands with dr. reddys
Posted by : GuestIt will be a marvellous situation for GSK to join hands with Dr. Reddys, as plenty of oppurtunities will come to boost and boast with wide range of products in future. Its really a win win situation for both gsk in india as well as UK and dr reddys world wide...
Good Opportunity to buy
Posted by : INOUPrice below 1500/= & hence a good opportunity to buy....
***H1N1 ( SWINE FLU ) VACCINE***
Posted by :
alfaromeo
H1N1 drug trial talks next week
Multinational drug firms Novartis, GlaxoSmithKline and Baxter are likely to initiate discussions with the Union health ministry next week on conducting clinical trials for H1N1 (swine flu) medicine.
The talks will include selection of sites, finalisation of trial modalities, price negotiation for vaccine supplies and advance placement of purchase orders.
Senior government officials say the companies are expected to agree to the ministry demand for experimental studies on 600–800 humans before applying for marketing licences. Eight centres from across the country have been shortlisted for these studies.
We are open to place advance purchase orders if they are willing to conduct clinical trials in the country; However, the prices will have to be negotiated, officials said. It is known that a single dose of H1N1 vaccine may cost between Rs 600 to Rs 800.
Earlier, addressing a press conference, health minister Ghulam Nabi Azad said the MNCs will not be given marketing permission unless studies are conducted in India. “They wanted to avoid it, as trials are going on in other countries. But we will have them conduct bridging studies here before allowing them to introduce their vaccines,” Azad said.
...
gsk pharma
Posted by : Guestwith the growing interest shown in indian pharma companies by gsk, it is imminent that GSK Pharma will grow by leap and bounds and will surely give bonus sooner or later in 2010....
GSK Fundamentals are very strong
Posted by : chief_kamanijalunm-GlaxoSmithKline Con is having superb Topline and Bottomline Growth!!I expect GlaxoSmithKline Con to move up further!!...
